Research Article
[Retracted] LAG3 and PD1 Regulate CD8+ T Cell in Diffuse Large B-cell Lymphoma Patients
Table 1
DLBCL patient characteristics of the study.
| Characteristics | Level/type | Value |
| Sex (%) | F | 18 (46.2) | M | 21 (53.8) | Age (mean (SD)) | | 59.8 (13.8) | Diagnosis (%) | DLBCL | 39 (100.0) | Fish | Double hit | 2 (5.1) | Therapy (%) | CHOP | 1 (2.6) | R-CHOP/CDOP | 36 (92.3) | R-DA-EPOCH | 2 (5.1) | Response in third course (%) | CR | 20 (51.3) | PD | 2 (5.1) | PR | 12 (30.8) | SD | 2 (5.1) | Unknown | 3 (7.7) | Response in sixth course (%) | CR | 25 (64.1) | PD | 4 (10.3) | PR | 2 (5.1) | SD | 1 (2.6) | Unknown | 7 (17.9) | Stage (%) | I | 2 (5.1) | II | 7 (18.0) | III | 3 (7.7) | IV | 27 (69.2) | IPI (%) | 0 | 0 (0) | 1 | 3 (7.7) | 2 | 4 (10.3) | 3 | 2 (5.1) | 4 | 4 (10.3) | 5 | 5 (12.7) | aaIPI (%) | 0 | 3 (7.7) | 1 | 4 (10.3) | 2 | 9 (23.0) | 3 | 4 (10.3) | 4 | 1 (2.6) | Increased LDH (%) | | 21 (53.8) | Increased ESR (%) | | 20 (51.3) | Increased CRP (%) | | 14 (35.9) | Increased β2MG (%) | | 20 (53.8) |
|
|